(Q44024987)

English

Long-term metabolic consequences of switching from protease inhibitors to efavirenz in therapy for human immunodeficiency virus-infected patients with lipoatrophy.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12060877%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Long-term metabolic consequences of switching from protease inhibitors to efavirenz in therapy for human immunodeficiency virus-infected patients with lipoatrophy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12060877%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

based on heuristic

inferred from title

Vicente Estrada

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12060877%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

N G P De Villar

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12060877%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M T Martínez Larrad

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12060877%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A González López

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12060877%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

C Fernández

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12060877%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Serrano-Rios

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12060877%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

0 references

publication date

7 June 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12060877%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12060877%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12060877%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12060877%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

69-76

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12060877%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Adverse effects of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F340863

21 January 2018

A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy

1 reference

https://api.crossref.org/works/10.1086%2F340863

21 January 2018

The HIV protease inhibitor indinavir decreases insulin- and contraction-stimulated glucose transport in skeletal muscle

1 reference

https://api.crossref.org/works/10.1086%2F340863

21 January 2018

Metabolic effects of indinavir in healthy HIV-seronegative men

1 reference

https://api.crossref.org/works/10.1086%2F340863

21 January 2018

Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy

1 reference

https://api.crossref.org/works/10.1086%2F340863

21 January 2018

Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine

1 reference

https://api.crossref.org/works/10.1086%2F340863

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1086%2F340863

21 January 2018

Mitochondrial toxicity of antiviral drugs

1 reference

https://api.crossref.org/works/10.1086%2F340863

21 January 2018

The mechanism of insulin resistance caused by HIV protease inhibitor therapy.

1 reference

https://api.crossref.org/works/10.1086%2F340863

21 January 2018

Surgical removal of visceral fat reverses hepatic insulin resistance.

1 reference

https://api.crossref.org/works/10.1086%2F340863

21 January 2018

Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes

1 reference

https://api.crossref.org/works/10.1086%2F340863

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44024987&oldid=2105745778"